Status:
COMPLETED
Meal Timing and Blood Pressure
Lead Sponsor:
University of Wisconsin, Madison
Collaborating Sponsors:
American Heart Association
Conditions:
Blood Pressure
Neurovascular Control
Eligibility:
All Genders
50-65 years
Phase:
NA
Brief Summary
Brain blood flow, blood pressure, and neurovascular control mechanisms will be measured in middle-aged adults before and after a brief intervention period. The intervention will consist of changing th...
Detailed Description
Healthy adults experience a 10-20% decrease in night-time blood pressure, compared with day-time blood pressure. However, 20-40% of middle-aged adults do not demonstrate a decrease in blood pressure. ...
Eligibility Criteria
Inclusion
- BMI ≤ 34 kg/m2
- Non-smoking
- Sedentary or recreationally active
- ≤ 2 Alcoholic drinks per day
- Female subjects: Perimenopausal/Postmenopausal
Exclusion
- History or evidence of hepatic, renal, hematological, peripheral vascular disease, or stroke/neurovascular disease, diabetes, uncontrolled hypertension, sleep apnea
- On medications used to treat/manage diseases listed above
- Work overnight shifts
- Clinically diagnosed anxiety or depression
- Pregnant or trying to become pregnant
- Significant surgical history
- Other significant medical conditions at investigator's discretion
Key Trial Info
Start Date :
February 2 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 16 2022
Estimated Enrollment :
34 Patients enrolled
Trial Details
Trial ID
NCT04133701
Start Date
February 2 2022
End Date
December 16 2022
Last Update
March 22 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Wisconsin-Madison
Madison, Wisconsin, United States, 53706